Strategic Alliance

Selected partner to fill the gaps

Resource Integration

Resource integration of Lihpao LifeScience Group

Project Acceleration

Force to generate real early momentum

Libo Pharma Corp.

Libo Pharma Corp. works with worldwide partner to accelerate novel therapeutics development.

In the virtual variant of the federated model, Libo Pharma Corp. operations are outsourced and the company itself acts as a management hub, coordinating the activities of its partners

  • Finding and developing molecules which are winners
  • Network of contractors
  • Activities coordinated by one company acting as hub
  • Operates on project-by-project basis
  • Fee-for-service financial structure

Business Model

Asset

HemaMax
HemaMax is a cytokine based therapeutics in the clinical development stage. Several combination trial is under development.
Explore our HemaMax Project
Stealth Mode Project
The project which is in the good shape at pre-IND/clinical stage running under the in-company stealth mode.
Explore our Stealth Mode Project